John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Qfin Holdings
QFIN
$1.38B
| $4.19M | 0.01% |
93,300
-92,239
| -50% | -$3.82M |
|
1177
SPX Corp
SPXC
$10.2B
| $4.14M | 0.01% |
32,159
+18,552
| +136% | +$2.66M |
|
1178
Ultrapar
UGP
$6.98B
| $4.13M | 0.01% |
1,341,648
-312,725
| -19% | -$896K |
|
1179
Kennametal
KMT
$2.22B
| $4.13M | 0.01% |
193,909
+79,296
| +69% | +$1.8M |
|
|
ELME
1180
Elme Communities
ELME
$149M
| $4.11M | 0.01% |
236,363
-86,791
| -27% | -$1.4M |
|
1181
First Bancorp
FBP
$4.29B
| $4.1M | 0.01% |
+214,066
| New | +$4.16M |
|
1182
PTC Therapeutics
PTCT
$6.06B
| $4.08M | 0.01% |
80,100
-93,252
| -54% | -$4.65M |
|
1183
Delek US
DK
$4.14B
| $4.08M | 0.01% |
270,711
+123,103
| +83% | +$2.13M |
|
1184
RUM Group Inc
RUM
$5.03B
| $4.07M | 0.01% |
575,775
+261,186
| +83% | +$2.72M |
|
1185
Kymera Therapeutics
KYMR
$10.3B
| $4.04M | 0.01% |
147,620
-26,133
| -15% | -$953K |
|
1186
Minerals Technologies
MTX
$2.23B
| $4.01M | 0.01% |
63,065
+23,411
| +59% | +$1.67M |
|
1187
Lakeland Financial Corp
LKFN
$1.48B
| $4.01M | 0.01% |
67,428
+60,589
| +886% | +$3.97M |
|
1188
QCR Holdings
QCRH
$1.64B
| $4M | 0.01% |
56,031
+32,721
| +140% | +$2.49M |
|
|
CLBR
1189
DELISTED
Colombier Acquisition Corp II
CLBR
| $3.99M | 0.01% |
375,000
| – | – |
|
1190
Johnson & Johnson
JNJ
$658B
| $3.97M | 0.01% |
23,957
-39,811
| -62% | -$6.23M |
|
1191
iShares Core S&P US Growth ETF
IUSG
$33.2B
| $3.96M | 0.01% |
31,194
-4,706
| -13% | -$651K |
|
|
EH
1192
EHang Holdings
EH
$378M
| $3.96M | 0.01% |
+189,642
| New | +$3.85M |
|
1193
Timken Company
TKR
$8.51B
| $3.96M | 0.01% |
55,102
-71,390
| -56% | -$5.51M |
|
1194
Redwire
RDW
$2.85B
| $3.96M | 0.01% |
477,651
+328,282
| +220% | +$5.44M |
|
1195
WisdomTree US SmallCap Earnings Fund
EES
$720M
| $3.96M | 0.01% |
81,000
+65,100
| +409% | +$3.43M |
|
1196
Wells Fargo
WFC
$254B
| $3.95M | 0.01% |
55,001
-458
| -0.8% | -$34.4K |
|
|
ESPR
1197
DELISTED
Esperion Therapeutics
ESPR
| $3.93M | 0.01% |
2,731,287
-809,074
| -23% | -$1.49M |
|
1198
PepsiCo
PEP
$195B
| $3.93M | 0.01% |
26,230
-588,438
| -96% | -$87.6M |
|
1199
Kforce
KFRC
$1.03B
| $3.93M | 0.01% |
80,349
+523
| +0.7% | +$27.2K |
|
1200
Revolve Group
RVLV
$1.65B
| $3.93M | 0.01% |
182,784
-113,871
| -38% | -$3.16M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.